ARTICLE | Company News
JNJ looking to revive Natrecor
February 25, 2006 3:16 AM UTC
The Scios subsidiary of Johnson & Johnson (JNJ) is restructuring to focus its resources on clinical research related to Natrecor nesiritide to "return the drug to growth," according to JNJ spokesperso...